FDA: Eisai drug increases acidosis risk

The FDA warned doctors that Eisai's epilepsy drug Zonegran can cause a metabolic disorder--acidosis--that can increase the risk of kidney stones and bone disease; the drug's label will be updated accordingly, the agency said. Report